Price Decline Prompts Columbia Care $25 Million Share Repurchase Program

Columbia Care Announces Launch of Share Repurchase Program

Company’s board of directors approves $25 million open market repurchase program

NEW YORK, July 19, 2019–(BUSINESS WIRE)–Columbia Care Inc. (NEO:CCHW) (OTCQX:CCHWF) (FSE:3LP) (“Columbia Care” or the “Company”), one of the largest fully integrated operators in the global medical cannabis industry with licenses across the US and EU, today announced its intention to commence a normal course issuer bid (the “Repurchase Program”) to purchase up to an aggregate of USD $25 million in common shares of the Company (the “Common Shares”). The actual number of Common Shares that may be purchased under the Repurchase Program and the exact timing of such purchases will be determined by the Company.

Columbia Care is undertaking the Repurchase Program because its management believes that, currently, and from time to time, the market price of its Common Shares may not reflect the underlying value of the Company’s business and prospects. Management believes that, at such times, the purchase of Common Shares for cancellation would be in the best interests of the Company’s shareholders and an appropriate use of its cash on hand.

The Repurchase Program has been approved by the Company’s board of directors and accepted by Neo Exchange Inc. (the “NEO Exchange” or the “NEO”) and will be executed in accordance with the applicable rules and policies of the NEO Exchange and any applicable Canadian securities laws. The Repurchase Program shall commence on July 23, 2019 and run through July 17, 2020 or on such earlier date as the Repurchase Program is complete.

Under the terms of the Repurchase Program, Columbia Care may, if considered advisable, purchase its Common Shares in open market transactions through the facilities of the NEO Exchange and/or alternative Canadian trading systems from time to time, not to exceed 10,798,037 Common Shares purchased in aggregate. The price that the Company will pay for the Common Shares shall be the prevailing market price at the time of purchase and all purchased Common Shares will be cancelled by the Company. In accordance with NEO Exchange rules, daily purchases (other than pursuant to a block purchase exception) on the NEO under the Repurchase Program cannot exceed 25% of the average daily trading volume on the NEO as measured from April 29, 2019 to July 12, 2019.

The Company has appointed Canaccord Genuity Corp. to coordinate and facilitate purchases under the Repurchase Program.

About Columbia Care Inc.

Columbia Care is one of the largest fully integrated operators in the global medical cannabis industry, with licenses across the US and EU. With over 1,000,000 successful sales transactions since its inception, Columbia Care is a patient-centered organization setting the standard for compassion, professionalism, quality, caring and innovation, working in collaboration with renowned and innovative teaching hospitals and medical centers. The Company is committed to providing the type of education and transparency patients deserve and quality of product that clinicians expect. For more information on Columbia Care, please visit www.col-care.com.

Original Press Release

Published by NCV Newswire

The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.